Your session is about to expire
← Back to Search
Fluoxetine for Poststroke Depression
Study Summary
This trial looks at whether treating depression can help people who have had a certain type of stroke.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2012 Phase 4 trial • 43 Patients • NCT00245635Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I speak and understand English.I was admitted for bleeding in the brain from a burst blood vessel.I do not have any health conditions that prevent me from taking fluoxetine.I am not currently receiving treatment for depression or any related mental health issues.I am between 18 and 85 years old.I can understand and agree to the study because my thinking is clear.
- Group 1: Treatment
- Group 2: Placebo
- Approved for 5 Other Conditions - This treatment demonstrated efficacy for 5 other conditions.
- All Individual Drugs Already Approved - Therapies where all constituent drugs have already been approved are likely to have better-understood side effect profiles.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
In what instances is Fluoxetine frequently prescribed?
"Fluoxetine has been demonstrated to be an effective remedy for myoclonus, unipolar depression, and obsessive-compulsive disorder."
To what extent has Fluoxetine been examined through the use of medical experiments?
"Currently, 15 clinical trials for Fluoxetine are in progress. Of these studies, two have advanced to Phase 3 testing. Most of the research is based out of New Haven Connecticut; however, multiple other sites across the country are also hosting research on this medication."
Who meets the qualifications for taking part in this medical experiment?
"This clinical trial seeks 224 participants afflicted with a hemorrhagic stroke, and must meet the following criteria: Between 18-85 years of age at admittance for subarachnoid hemorrhage stemming from ruptured cerebral aneurysm."
To what extent has Fluoxetine been determined to be a hazard to individuals?
"Data surrounding Fluoxetine's safety is promising, as it has been rated a 2 on our 1-3 scale. This indicates that there is some evidence of security but none yet supporting its efficacy in this Phase 2 study"
Is enrollment still open for this clinical investigation?
"Yes, according to clinicaltrials.gov this trial is currently recruiting participants for its study which began on March 1st 2019 and was last updated at the end of October 2022. 224 individuals are needed from a singular medical site."
Is the minimum age requirement of this trial over twenty years old?
"The criteria for this clinical trial states that an eligible patient must be between the ages of 18 and 85. For those under 18, there are 233 studies available while persons above 65 have access to 2011 trials."
What is the recruitment size for this medical trial?
"Affirmative. Primary source data from clinicaltrials.gov shows that this investigation, first posted on March 1st 2019, is currently recruiting 224 patients for one site. Last updates were made on October 31st 2022."
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger